FDA — authorised 23 May 1994
- Application: BLA020367
- Marketing authorisation holder: GENZYME
- Local brand name: CEREZYME
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Cerezyme® in United States
FDA authorised Cerezyme® on 23 May 1994
Marketing authorisation
Cerezyme® in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare genetic disease / Lysosomal storage disorder approved in United States
Frequently asked questions
Is Cerezyme® approved in United States?
Yes. FDA authorised it on 23 May 1994.
Who is the marketing authorisation holder for Cerezyme® in United States?
GENZYME holds the US marketing authorisation.